(1 - 21 von 37
)
Takeda's Cambridge team gets role in new neurological drug ...
www.cambridge-news.co.uk
... promising CNS programs and scientists in an entrepreneurial setting," said Dr Andrew Plump, chief medical and scientific officer at Takeda.
Takeda Announces Appointment of Andrew Plump, M.D., Ph.D., as Chief...
www.takeda.com
Takeda Announces Appointment of Andrew Plump, M.D., Ph.D., as Chief Medical and Scientific Officer
Unraveling heart disease to push the science forward
alumni.ucsf.edu
Andrew Plump, MD '95, PhD, will never forget the Saturday night in when he saw proof that he had indeed given heart disease to a mouse using ... › stories › a...
Walk toward a Healthy Heart at Nomahegan Park in Cranford, June
www.nj.com
The Annual American Heart Association Mid-Jersey Start! Heart Walk is scheduled for Saturday, June 4, at Nomahegan Park in Cranford. Registration is at 8:30...
Exceptional Alumni Honored with New Award Inspired by UCSF: The...
www.ucsf.edu
The Alumni Association of UCSF has named 12 winners of the inaugural UCSF Campaign Alumni Awards to highlight the remarkable work of some of UCSF’s most...
Takeda Spins Out Research Team Into Neuroscience Startup
www.genengnews.com
Pharma joins Lightstone Ventures to help launch Cerevance, which will develop the…utics for neurological and psychiatric disorders
Takeda and Crescendo create cancer partnership -
pharmaphorum.com
Takeda has joined with UK-based biotech Crescendo Biologics in a cancer drug development deal worth up to $790 million.
Takeda R&D chief: Shire deal will accelerate plans by three to five...
www.statnews.com
Takeda is borrowing cash to pay for Shire, worrying shareholders about its debt load. Up to 7 percent of 52,000 workers will lose their jobs. And Takeda will...
More efficiency, transparency and diversity in ICC Arbitration
iccwbo.org
— Roland Ziade and Andrew Plump of Linklaters discuss their views on the recent developments in ICC Arbitration in their latest guest blog for ... › news-speeches
Takeda forms new women's health and cancer company - PMLiVE
www.pmlive.com
Andrew Plump, chief medical and scientific officer at Takeda, said that Myovant will succeed in bringing relugolix to market by uniting the new ...
Pioneering drug discovery company Bridge Medicines ...
www.rockefeller.edu
— From left to right: Augustine Choi, Craig Thompson, Richard Lifton, Andrew Plump, Carl Goldfischer, James Flynn, and Michael Foley join to ... › news
Takeda appoints new chief medical and scientific officer
www.biospectrumasia.com
Dr Andrew Plump has joined Takeda as corporate officer and chief medical and scientific officer
Takeda restructuring results in Cambridge biotech spinout | BioPharma...
www.biopharmadive.com
BioPharma
Rare mutation prompts race for cholesterol drug
eu.dispatch.com
— “This is our top priority,” said Dr. Andrew Plump, the head of translational medicine at Sanofi. “Nothing else we are doing has the same ... › health-fitness ›
Takeda signs strategic-level outsourcing deal with PRA - PMLiVE
www.pmlive.com
Recently-appointed R&D chief Andrew Plump told investors in June that Takeda needed to transform its R&D and rebuild its pipeline "to a level ...
Takeda to Acquire TiGenix for €520M
www.genengnews.com
Deal designed to strengthen Takeda’s late-stage gastroenterology pipeline and presence in the U.S. specialty care market
With new deal, Takeda's R&D chief promises an 'inflection year'
www.statnews.com
— The deal is a small one, but for R&D chief Andrew Plump, it represents a research and development transformation playing out at the company ... › as-take...
sortiert nach Relevanz / Datum